Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials.

scientific article

Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1016/J.IJCARD.2014.09.028
P698PubMed publication ID25499365

P50authorBruno TrimarcoQ38321707
Gianluigi SavareseQ43125824
Giovanni G. CamiciQ55483552
Martin F ReinerQ59175999
P2093author name stringPasquale Perrone-Filardi
Giuseppe M C Rosano
Antonio Parente
Carmen D'Amore
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)152-160
P577publication date2014-09-28
P1433published inInternational Journal of CardiologyQ2357863
P1476titleReduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials
P478volume177

Reverse relations

cites work (P2860)
Q34529921CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study
Q38535519Inflammatory markers and cardiometabolic diseases
Q38611526Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium

Search more.